AMG-548

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameAMG-548

Drug Alias NameAMG-548

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionP38 γ mitogen-activated protein kinase inhibitorsTumor necrosis factor α inhibitors

TargetsP38 γ mitogen-activated protein kinaseTumor necrosis factor α

Therapy Area/IndicationsArthritis, RheumatoidArthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmgen Inc

Active IndicationsN/A

Inactive IndicationsArthritis, RheumatoidArthritis

ATC CodeN/A